🟢 Rocket Pharmaceuticals is trading 5% up today without a clear company-specific catalyst

Rocket Pharmaceuticals is trading 5.21% up now at $2.73, with no clear company-specific announcement or catalyst identified for September 30, 2026.

• Its latest listed company news was September 15, concerning FDA alignment on its Danon disease trial.
• Broader markets were higher: the S&P 500 rose 0.60% and Nasdaq 1.03%. This risk-on backdrop may have contributed, but the available evidence does not establish it as the direct cause.